Treatment Patterns, Treatment Outcomes, and Health Care Costs Before and After Humulin R U-500 Initiation or Device Change among Patients with Type 2 Diabetes in the United States (U500 RWE)

Study identification

• EU PAS number:
  EUPAS39154
• Study ID:
  39155
• Official title and acronym:
  Treatment Patterns, Treatment Outcomes, and Health Care Costs Before and After Humulin R U-500 Initiation or Device Change among Patients with Type 2 Diabetes in the United States (U500 RWE)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  1. Examine treatment patterns before an after U-500R initiation/Device Change, 2. Understand factors associated with observed treatment pattern changes,
• Study status:
  Finalised

Research institutions and networks

Institutions

Eli Lilly and Company

Study timelines

Date when funding contract was signed

Planned:29/09/2018

Actual:30/09/2018

Study start date

Planned:01/10/2018

Actual:01/10/2018

Data analysis start date

Planned:01/11/2018

Actual:01/11/2018

Date of final study report

Planned:05/01/2021

Actual:05/01/2021

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Eli Lilly and Company

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable